SFN in combination with chemotherapeutic agents was found to regulate MAPK, Akt/mTOR, NF-κB, Wnt/β-catenin, and STAT3 signaling cascades, thereby inducing the reversal of drug resistance in cancer cells. The gene discussed is MTOR; the disease is cancer.